The Government of Canada has secured COVID-19 vaccines from Pfizer for 2022 and 2023, with options to extend into 2024.
The agreement guarantees access to 65 million doses of Pfizer-BioNTech’s COVID-19 vaccine, with access to up to 120 million more if all options are exercised, Ottawa says.
In addition to providing booster vaccine doses, the agreement provides flexibility to procure future COVID-19 vaccine formulations from Pfizer, such as those to protect against variants of concern and vaccines developed for children.
These doses are in addition to the 48 million doses of Pfizer-BioNTech’s COVID-19 vaccine arriving before the end of September 2021 as part of Canada’s existing agreement.
For 2023, Canada has secured access to a guaranteed 30 million doses, with options for 30 million more.
The Pfizer-BioNTech COVID-19 mRNA vaccine was approved by Health Canada for people who are 16 years of age and older.
“The Government of Canada is working tirelessly to protect everyone in Canada from COVID-19. This means getting doses for everyone who wants one before the end of this September and securing doses for 2022 and beyond,” says Anita Anand, Minister of Public Services and Procurement.